Published in J Clin Sleep Med on June 15, 2007
Sleep apnea prevalence in acute myocardial infarction--the Sleep Apnea in Post-acute Myocardial Infarction Patients (SAPAMI) Study. Int J Cardiol (2014) 2.03
Relation of obstructive sleep apnea to coronary artery calcium in non-obese versus obese men and women aged 45-75 years. Am J Cardiol (2014) 1.45
Hypertension, snoring, and obstructive sleep apnoea during pregnancy: a cohort study. BJOG (2014) 1.41
Evaluation of a single-channel portable monitor for the diagnosis of obstructive sleep apnea. J Clin Sleep Med (2011) 1.16
Sleep apnea treatment after stroke (SATS) trial: is it feasible? J Stroke Cerebrovasc Dis (2011) 1.14
The utility of single-channel nasal airflow pressure transducer in the diagnosis of OSA at home. Sleep (2010) 1.12
A Comprehensive Evaluation of a Two-Channel Portable Monitor to "Rule in" Obstructive Sleep Apnea. J Clin Sleep Med (2015) 1.07
Is technologist review of raw data necessary after home studies for sleep apnea? J Clin Sleep Med (2014) 0.98
Interaction between Sleep-Disordered Breathing and Acute Ischemic Stroke. J Clin Neurol (2013) 0.97
Sleep-disordered breathing in the National Football League. Sleep (2010) 0.96
Evaluation of the accuracy of manual and automatic scoring of a single airflow channel in patients with a high probability of obstructive sleep apnea. Med Sci Monit (2011) 0.96
Comparison between a single-channel nasal airflow device and oximetry for the diagnosis of obstructive sleep apnea. Sleep (2010) 0.95
Effectiveness of home single-channel nasal pressure for sleep apnea diagnosis. Sleep (2014) 0.88
Brainstem infarction and sleep-disordered breathing in the BASIC sleep apnea study. Sleep Med (2014) 0.87
The utility of a portable recording device for screening of obstructive sleep apnea in obese adolescents. J Clin Sleep Med (2012) 0.87
Detection of sleep disordered breathing and its central/obstructive character using nasal cannula and finger pulse oximeter. J Clin Sleep Med (2012) 0.87
Validation of ApneaLink as screening device for Cheyne-Stokes respiration. Sleep (2009) 0.86
Evaluation of a single-channel nasal pressure device to assess obstructive sleep apnea risk in laboratory and home environments. J Clin Sleep Med (2013) 0.86
Validation of the MediByte® type 3 portable monitor compared with polysomnography for screening of obstructive sleep apnea. Can Respir J (2011) 0.85
The utility of a portable sleep monitor to diagnose sleep-disordered breathing in a pediatric population. Can Respir J (2013) 0.85
Disparities in sleep characteristics by race/ethnicity in a population-based sample: Chicago Area Sleep Study. Sleep Med (2015) 0.84
The role of single-channel nasal airflow pressure transducer in the diagnosis of OSA in the sleep laboratory. J Clin Sleep Med (2010) 0.83
Management of sleep apnea without high pretest probability or with comorbidities by three nights of portable sleep monitoring. Sleep (2014) 0.82
Efficacy of home single-channel nasal pressure for recommending continuous positive airway pressure treatment in sleep apnea. Sleep (2015) 0.81
Sleep apnea is related to the atherogenic phenotype, lipoprotein subclass B. J Clin Sleep Med (2012) 0.81
Validation of the Behavioral Risk Factor Surveillance System Sleep Questions. J Clin Sleep Med (2015) 0.81
Associations of moderate to severe asthma with obstructive sleep apnea. Yonsei Med J (2013) 0.80
Targeted case finding for OSA within the primary care setting. J Clin Sleep Med (2013) 0.80
Ischemic stroke subtype and presence of sleep-disordered breathing: the BASIC sleep apnea study. J Stroke Cerebrovasc Dis (2014) 0.80
The association between sleep characteristics and prothrombotic markers in a population-based sample: Chicago Area Sleep Study. Sleep Med (2014) 0.78
Early diagnosis of sleep related breathing disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg (2010) 0.78
Sleep-disordered breathing in patients with heart failure. Heart Fail Clin (2014) 0.77
Determining the prevalence and predictors of sleep disordered breathing in patients with chronic heart failure: rationale and design of the SCHLA-HF registry. BMC Cardiovasc Disord (2014) 0.77
Automated sleep apnea quantification based on respiratory movement. Int J Med Sci (2014) 0.77
Validation of a portable monitor for the diagnosis of obstructive sleep apnea in morbidly obese patients. J Clin Sleep Med (2014) 0.77
The Validity and Reliability of an Arabic Version of the STOP-Bang Questionnaire for Identifying Obstructive Sleep Apnea. Open Respir Med J (2015) 0.76
How few signals are needed to diagnose sleep apnea? Sleep (2014) 0.76
Subclinical sleep apnoea and plasma levels of endothelin-1 among young and healthy adults. Open Heart (2017) 0.75
Indication of CPAP in Patients with Suspected Obstructive Sleep Apnea, Based on Clinical Parameters and a Novel Two-Channel Recording Device (ApneaLink): A Pilot Study. Sleep Disord (2012) 0.75
Screening for Obstructive Sleep Apnea in Type 2 Diabetes Patients - Questionnaires Are Not Good Enough. Front Endocrinol (Lausanne) (2016) 0.75
Are we ready for "unisomnography"? Sleep (2015) 0.75
Sleep apnea prevalence in chronic kidney disease - association with total body water and symptoms. BMC Nephrol (2017) 0.75
Utility of portable monitoring in the diagnosis of obstructive sleep apnea. J Postgrad Med (2015) 0.75
High prevalence of poststroke sleep-disordered breathing in Mexican Americans. Sleep Med (2016) 0.75
Predictors of Increased Daytime Sleepiness in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. Sleep Disord (2016) 0.75
Computer-Assisted Diagnosis of the Sleep Apnea-Hypopnea Syndrome: A Review. Sleep Disord (2015) 0.75
Exploding Head Syndrome with Co-morbid Sleep Apnea. Oman Med J (2017) 0.75
Hypoglossal nerve dysfunction and sleep-disordered breathing after stroke. Neurology (2014) 0.75
Evaluation of candidate measures for home-based screening of sleep disordered breathing in Taiwanese bus drivers. Sensors (Basel) (2014) 0.75
Obstructive Sleep Apnea Screening Using a Piezo-Electric Sensor. J Korean Med Sci (2017) 0.75
Obstructive sleep apnea might trigger acute pulmonary embolism: results from a cohort study. Clin Res Cardiol (2016) 0.75
Longitudinal assessment of daily activity patterns on weight change after involuntary job loss: the ADAPT study protocol. BMC Public Health (2017) 0.75
Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12
Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med (2002) 14.26
Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med (2001) 12.29
Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep (1997) 5.66
Access to diagnosis and treatment of patients with suspected sleep apnea. Am J Respir Crit Care Med (2004) 5.43
Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med (2002) 5.15
Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation (1998) 4.56
Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med (2002) 4.35
Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med (1999) 4.09
Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care (2003) 3.21
Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med (1999) 2.72
The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep (2001) 2.59
Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep (1997) 2.48
Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab (1994) 2.23
Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep (2003) 2.21
Sleep apnea--a major public health problem. N Engl J Med (1993) 2.02
Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep (1999) 1.94
Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension. Thorax (2004) 1.42
[Validation of microMESAM as screening device for sleep disordered breathing]. Pneumologie (2003) 1.28
Obstructive sleep apnoea and cardiovascular disease. Intern Med J (2004) 1.19
High incidence of sleep apnea syndrome in a male diabetic population. Diabetes Res Clin Pract (1991) 0.97
Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract (2009) 7.06
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care (2009) 5.41
AACE comprehensive diabetes management algorithm 2013. Endocr Pract (2013) 4.88
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract (2011) 4.69
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract (2009) 3.96
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2016 EXECUTIVE SUMMARY. Endocr Pract (2016) 3.01
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract (2013) 2.97
Adherence to and effectiveness of positive airway pressure therapy in children with obstructive sleep apnea. Pediatrics (2006) 2.42
Tobacco-cessation services and patient satisfaction in nine nonprofit HMOs. Am J Prev Med (2005) 2.11
Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract (2007) 1.88
Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes. Sleep (2007) 1.73
Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer (2006) 1.54
Comparison between automatic and fixed positive airway pressure therapy in the home. Am J Respir Crit Care Med (2002) 1.49
Aace/Ace comprehensive diabetes management algorithm 2015. Endocr Pract (2015) 1.43
American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract (2011) 1.41
Gay/Lesbian sexual orientation increases risk for cigarette smoking and heavy drinking among members of a large Northern California health plan. BMC Public Health (2006) 1.35
Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function. Anesthesiology (2010) 1.27
Relationship between tobacco control policies and the delivery of smoking cessation services in nonprofit HMOs. J Natl Cancer Inst Monogr (2005) 1.22
Evaluation of a single-channel portable monitor for the diagnosis of obstructive sleep apnea. J Clin Sleep Med (2011) 1.16
Tobacco-control policies in 11 leading managed care organizations: progress and challenges. Eff Clin Pract (2002) 1.16
Lead ions do not cause human lung cells to escape chromate-induced cytotoxicity. Toxicol Appl Pharmacol (2005) 1.15
Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force. Endocr Pract (2007) 1.12
Lead chromate-induced chromosome damage requires extracellular dissolution to liberate chromium ions but does not require particle internalization or intracellular dissolution. Chem Res Toxicol (2004) 1.08
The clinical approach to the detection of lipodystrophy - an AACE consensus statement. Endocr Pract (2013) 1.02
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS. Endocr Pract (2016) 0.97
Hypoglycemia in type 2 diabetes: current controversies and changing practices. Front Endocrinol (Lausanne) (2012) 0.95
Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc (2011) 0.95
p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels. J Med Chem (2010) 0.93
Diabetes and cancer--an AACE/ACE consensus statement. Endocr Pract (2013) 0.91
Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis. Pediatr Blood Cancer (2013) 0.90
Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity. Surg Obes Relat Dis (2008) 0.90
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. Endocr Pract (2017) 0.90
Proceedings from the american association of clinical endocrinologists and american college of endocrinology consensus conference on glucose monitoring. Endocr Pract (2015) 0.87
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY. Endocr Pract (2015) 0.85
Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs. J Aerosol Med Pulm Drug Deliv (2010) 0.85
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2015 EXECUTIVE SUMMARY. Endocr Pract (2015) 0.80
The Digital Divide and Patient Portals: Internet Access Explained Differences in Patient Portal Use for Secure Messaging by Age, Race, and Income. Med Care (2016) 0.80
Ku80 deficiency does not affect particulate chromate-induced chromosome damage and cytotoxicity in Chinese hamster ovary cells. Toxicol Sci (2007) 0.80
Aerosol interleukin-2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis. Pediatr Blood Cancer (2014) 0.80
Hemoglobin A1c in diabetes diagnosis: time for caution. Endocr Pract (2010) 0.80
Mutations in the GABAA receptor that mimic the allosteric ligand etomidate. Methods Mol Biol (2012) 0.80
Evaluation of auto bi-level algorithm to treat pressure intolerance in obstructive sleep apnea. Sleep Breath (2010) 0.80
PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALS. Endocr Pract (2015) 0.78
Knockdown of autophagy-related protein 5, ATG5, decreases oxidative stress and has an opposing effect on camptothecin-induced cytotoxicity in osteosarcoma cells. BMC Cancer (2013) 0.78
Autophagy in osteosarcoma. Adv Exp Med Biol (2014) 0.78
Patient-initiated e-mails to providers: associations with out-of-pocket visit costs, and impact on care-seeking and health. Am J Manag Care (2015) 0.77
COMBINING CREATININE-BASED eGFR WITH CYSTATIN C-BASED EGFR TO BETTER ASSESS RENAL FUNCTION IN PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE 3A: IMPLICATIONS FOR DRUG SELECTION AND DOSAGE IN TYPE 2 DIABETES. Endocr Pract (2015) 0.75
Effectiveness of primary care-relevant treatments for obesity in adults. Ann Intern Med (2012) 0.75
AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES. Endocr Pract (2017) 0.75
Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipids. J Diabetes (2011) 0.75
REVISITING THE USE OF PIOGLITAZONE IN THE TREATMENT OF TYPE 2 DIABETES. Endocr Pract (2016) 0.75
The Journal of diabetes: continuing the dialogue. J Diabetes (2013) 0.75